- Home
- QURE vs CDRE Comparison
QURE vs CDRE Comparison
Compare QURE & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | CDRE |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | QURE | CDRE |
|---|---|---|
| Price | $17.61 | $31.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $44.92 | $39.67 |
| AVG Volume (30 Days) | ★ 1.6M | 355.0K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | ★ 29.67 | 13.33 |
| EPS | N/A | ★ 1.02 |
| Revenue | $13,107,000.00 | ★ $610,308,000.00 |
| Revenue This Year | $126.12 | $23.72 |
| Revenue Next Year | $200.43 | $6.89 |
| P/E Ratio | ★ N/A | $29.85 |
| Revenue Growth | N/A | ★ 7.53 |
| 52 Week Low | $8.73 | $28.22 |
| 52 Week High | $71.50 | $48.76 |
Technical Indicators
Market Signals| Indicator | QURE | CDRE |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 40.78 |
| Support Level | $13.47 | $28.71 |
| Resistance Level | $18.37 | $31.48 |
| Average True Range (ATR) | 1.33 | 1.37 |
| MACD | 0.27 | 0.32 |
| Stochastic Oscillator | 87.86 | 40.54 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.